Literature DB >> 22664918

MicroRNA expression changes after lung cancer resection: a follow-up study.

Petra Leidinger1, Andreas Keller, Christina Backes, Hanno Huwer, Eckart Meese.   

Abstract

MiRNAs are powerful biomarkers for detecting various diseases from tissue and body fluids. The potential of these molecules to monitor patients over time has, however, been less explored. We followed the fate of the plasma miRNome of lung cancer patients starting prior to surgery and ending 18 mo after surgery, with blood taken at three-month intervals. Principal component and clustering analysis showed that the differences of the overall miRNA patterns between the different time points were significantly smaller than between patients. For each patient we found a rather specific fluctuating miRNA pattern. We identified miRNAs that showed a significant correlation between expression level and time distance from surgery. A network analysis revealed 12 correlated miRNAs regulating 48 genes that were deregulated in lung cancer tissue. Our data underline the importance of studies that follow the fate of miRNAs over time, both to further our understanding of the biology of miRNA signatures and to establish these signatures as biomarkers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22664918     DOI: 10.4161/rna.20107

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  14 in total

1.  Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma.

Authors:  Nicholas Latchana; Mallory J DiVincenzo; Kelly Regan; Zachary Abrams; Xiaoli Zhang; Naduparambil K Jacob; Alejandro A Gru; Paolo Fadda; Joseph Markowitz; J Harrison Howard; William E Carson
Journal:  J Surg Oncol       Date:  2018-08-21       Impact factor: 3.454

Review 2.  miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Authors:  Mateusz Florczuk; Adam Szpechcinski; Joanna Chorostowska-Wynimko
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

3.  Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.

Authors:  Junbo Xia; Man Luo; Lujun Dai; Liusheng Wang; Limin Wang; Jing Zhu
Journal:  J Clin Lab Anal       Date:  2021-03-08       Impact factor: 2.352

4.  Longitudinal study on circulating miRNAs in patients after lung cancer resection.

Authors:  Petra Leidinger; Valentina Galata; Christina Backes; Cord Stähler; Stefanie Rheinheimer; Hanno Huwer; Eckart Meese; Andreas Keller
Journal:  Oncotarget       Date:  2015-06-30

5.  The human miRNA repertoire of different blood compounds.

Authors:  Petra Leidinger; Christina Backes; Benjamin Meder; Eckart Meese; Andreas Keller
Journal:  BMC Genomics       Date:  2014-06-14       Impact factor: 3.969

6.  What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls.

Authors:  Petra Leidinger; Christina Backes; Indra N Dahmke; Valentina Galata; Hanno Huwer; Ingo Stehle; Robert Bals; Andreas Keller; Eckart Meese
Journal:  Oncotarget       Date:  2014-10-15

7.  Identification of serum microRNA biomarkers for tuberculosis using RNA-seq.

Authors:  Hongtai Zhang; Zhaogang Sun; Wenjing Wei; Zhonghui Liu; Joy Fleming; Shuai Zhang; Nan Lin; Ming Wang; Maoshan Chen; Yuhui Xu; Jie Zhou; Chuanyou Li; Lijun Bi; Guangming Zhou
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

Review 8.  MicroRNAs-role in lung cancer.

Authors:  Małgorzata Guz; Adolfo Rivero-Müller; Estera Okoń; Agnieszka Stenzel-Bembenek; Krzysztof Polberg; Maria Słomka; Andrzej Stepulak
Journal:  Dis Markers       Date:  2014-03-13       Impact factor: 3.434

9.  The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases.

Authors:  Petra Leidinger; Christina Backes; Michael Blatt; Andreas Keller; Hanno Huwer; Philipp Lepper; Robert Bals; Eckart Meese
Journal:  Mol Cancer       Date:  2014-08-30       Impact factor: 27.401

Review 10.  Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.

Authors:  Francesca Moretti; Paola D'Antona; Emanuele Finardi; Marco Barbetta; Lorenzo Dominioni; Albino Poli; Elisabetta Gini; Douglas M Noonan; Andrea Imperatori; Nicola Rotolo; Maria Cattoni; Paola Campomenosi
Journal:  Oncotarget       Date:  2017-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.